Virax Biolabs Group Limited Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| HRT FINANCIAL LP | 11/14/2025 | 60.07 K | $36.00 K | 100.00% | 1.94% |
| VIRTU FINANCIAL LLC | 11/14/2025 | 21.38 K | $13.00 K | 100.00% | 0.69% |
| NATIONAL BANK OF CANADA /FI/ | 11/14/2025 | 10.00 K | $6.00 K | 100.00% | 0.32% |
| UBS GROUP AG | 11/13/2025 | 3.36 K | $2.04 K | 100.00% | 0.11% |
| CITADEL ADVISORS LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Virax Biolabs Group Limited institutional Ownership - FAQ's
During the previous two years, 5 institutional investors and hedge funds held shares of Virax Biolabs Group Limited. The most heavily invested institutionals were:
HRT FINANCIAL LP: 60,073
Virtu Financial LLC: 21,376
NATIONAL BANK OF CANADA /FI/: 10,000
UBS Group AG: 3,360
CITADEL ADVISORS LLC: 0
3.06% of Virax Biolabs Group Limited stock is owned by institutional investors.
Institutional investors have bought a total of 94.81 K shares in the last 24 months. This purchase volume represents approximately $61.06 K in transactions.